NASDAQ: VVOS
Vivos Therapeutics Inc Stock Ownership - Who owns Vivos Therapeutics?

Insider buying vs selling

Have Vivos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael C. Skaff10% Owner2026-03-311,044,777$1.34
$1.40MBuy
Michael C. Skaff10% Owner2026-03-31308,848$1.34
$413.86kBuy

1 of 1

VVOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VVOS insiders and whales buy or sell their stock.

VVOS Shareholders

What type of owners hold Vivos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gurdev Dave Singh35.82%3,219,705$4.25MInsider
Michael C. Skaff30.00%2,696,123$3.56MInsider
Ronald Kirk Huntsman20.27%1,822,061$2.41MInsider
Vanguard Group Inc3.38%304,161$401.49kInstitution
Drw Securities LLC1.29%115,907$153.00kInstitution
Geode Capital Management LLC0.63%56,287$74.30kInstitution
B Riley Wealth Advisors Inc0.48%43,531$57.46kInstitution
Commonwealth Equity Services LLC0.45%40,500$53.46kInstitution
Blackrock Inc0.31%27,817$36.72kInstitution
State Street Corp0.28%24,922$32.90kInstitution

1 of 3

VVOS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VVOS7.32%86.14%Net BuyingNet Buying
MODD65.04%34.96%
LFWD2.70%97.30%Net Selling
AIMD1.60%98.40%Net BuyingNet Selling
SINT6.90%74.16%Net BuyingNet Buying

Vivos Therapeutics Stock Ownership FAQ

Who owns Vivos Therapeutics?

Vivos Therapeutics (NASDAQ: VVOS) is owned by 7.32% institutional shareholders, 86.14% Vivos Therapeutics insiders, and 6.54% retail investors. Gurdev Dave Singh is the largest individual Vivos Therapeutics shareholder, owning 3.22M shares representing 35.82% of the company. Gurdev Dave Singh's Vivos Therapeutics shares are currently valued at $4.25M.

If you're new to stock investing, here's how to buy Vivos Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.